Omada Health (OMDA) - Forward P/S Multiple

Brandmark of Omada Health, Inc. (OMDA)

Omada Health Inc (OMDA) maintains a stable cloud infrastructure that ensures uninterrupted access to medical services. The projected price-to-sales ratio reflects current dynamics, with the metric standing at 1.10. The company minimizes risks by attracting insurance funds and employers. A broad range of hypertension and diabetes programs helps effectively allocate financial flows and reduce treatment costs.

Omada Health - OMDA Forward P/S Multiple (period 06/07/2025 - 11/13/2026)

Analytical breakdowns for Omada (OMDA)

- current price and projected stock value:
Summary company analysis:Omada Health (OMDA)
Manufactured products of Omada

Omada Health Inc (OMDA) is developing a digital ecosystem for chronic disease management through B2B integration. The projected P/S multiple illustrates the market value dynamics relative to expected revenue over a long-term horizon. Extreme indicator values signal asset overheating or undervaluation, requiring strict discipline from the strategist during rebalancing. A high forward multiple is justified by low corporate client churn due to the complexity of switching software.

Key competitors

Forward P/S Multiple VEEV (Veeva)|Forward Price to Sales DOCS|HealthEquity Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Waystar Corp|CRVL: Forward P/S Multiple|priviahealth.com (PRVA) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Huron|Price-to-Projected Revenue Ratio CERT|Forward Price-to-Revenue Multiple OMCL (Omnicell Corp)|Price to Expected Revenue Ratio GDRX|Forward P/S Multiple SDGR (Schrodinger, Inc.)|Forward Price to Sales PHR|EVH: Forward Price-to-Revenue Multiple|Forward Price to Sales HSTM (HealthStream Inc)|DH: Forward P/S Multiple|CCSI - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Agilon Health|Market Cap to Projected Revenue ABSI (absci.com)|Forward P/S Multiple SY|Forward Price-to-Revenue Multiple NRC Health NRC|Price-to-Projected Revenue Ratio Spok Corp SPOK|OptimizeRx Inc. (OPRX) - Market Cap to Future Revenue Ratio|TBRG - Price-to-Projected Revenue Ratio|simulations-plus.com (SLP) - Forward Price-to-Revenue Multiple|SOPH: Forward P/S Multiple|Market Cap to Projected Revenue HCAT|CCLD (CareCloud Inc.) - Forward P/S Multiple|Forward P/S Multiple Research Solutions Inc.|Forward P/S Multiple DLHC|Market Cap to Expected Sales Ratio onemednet.com|Scienture - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio HCTI (Healthcare Triangle Inc)|ISPC: Forward Price-to-Revenue Multiple|Forward Price to Sales BFRG (Bullfrog AI Holdings)|SCWorx Corp. (WORX) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple msprecovery.com|ICCT (iCoreConnect, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio TRxADE HEALTH Inc MEDS|Forward P/S Multiple ORGS|r1rcm.com - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Sharecare, Inc. SHCR|streamlinehealth.net (STRM) - Market Cap to Future Revenue Ratio|SYRA - Price-to-Projected Revenue Ratio|Apollo Medical Holdings (AMEH) - Forward Price-to-Revenue Multiple|MODN: Forward P/S Multiple|NextGen Healthcare Corp (NXGN) - Forward P/S Multiple